The International Vaccines Institute (IVI) is impressed with Kenya's progress in ensuring local manufacturing of health products and technologies is actualized.

IVI Director General Dr. Jerome Kim expressed his satisfaction with the strides made by Kenya while meeting Health CS Susan Nakhumicha at Afya House Monday.

The CS and her guest explored ways that both the IVI and Kenya's Biovax Institute will work together in ensuring Biovax's mandate is achieved.

The areas explored included research, partnerships in product development, capacity building of local workforce through trainings,technical assistance and technology transfers.

Kenya's bid to start manufacturing human vaccines, biotherapeutics & diagnostics begun when it formally presented a letter of intent to join the International Vaccine Institute as a state party.

The letter was presented by Foreign Affairs CS Dr. Alfred Mutua and witnessed by President William Ruto and CS Nakhumicha in Seul, South Korea in November 2022.

Kenya Biovax Institute is the state corporation mandated with manufacturing of specialised health products including vaccines and therapeutics.